Ancient and Modern: Hints of a Core Post-Transcriptional Network Driving Chemotherapy Resistance in Ovarian Cancer

Wiley Interdisciplinary Reviews: RNA - United States
doi 10.1002/wrna.1432
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Unique Proteome Signature of Post-Chemotherapy Ovarian Cancer Ascites-Derived Tumor Cells

Scientific Reports
Multidisciplinary
2016English

MicroRNAs 125a and 125b Inhibit Ovarian Cancer Cells Through Post-Transcriptional Inactivation of EIF4EBP1

Oncotarget
Oncology
2015English

Modern Concepts of Ovarian Cancer

Reports of Vinnytsia National Medical University
2019English

Intraperitoneal Chemotherapy in Ovarian Cancer: A Review of Tolerance and Efficacy

Cancer Management and Research
Oncology
2012English

G08Feasibility and Tolerability of Intraperitoneal Chemotherapy in Ovarian Cancer

Annals of Oncology
MedicineOncologyHematology
2016English

P11.06: Could LARP1 Be a Driving Force in Ovarian Cancer Transformation?

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

Prediction of Clinical Response to Drugs in Ovarian Cancer Using the Chemotherapy Resistance Test (CTR-test)

Journal of Ovarian Research
GynecologyOncologyObstetrics
2017English

Mitigating Cisplatin Resistance in Ovarian Cancer.

English

Pasteurella multocidaBacteremia in a Patient With Ovarian Cancer and Chemotherapy-Induced Neutropenia

Infectious Diseases in Obstetrics and Gynecology
DermatologyGynecologyInfectious DiseasesObstetrics
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy